The impact of genetic hypertension on insulin secretion and glucoregulatory control in vivo
- 1 March 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 16 (3) , 369-376
- https://doi.org/10.1097/00004872-199816030-00014
Abstract
To examine the associations among hypertension, insulin secretion, glucose tolerance and insulin resistance in vivo. Glucose tolerance and insulin secretion during an intravenous glucose tolerance test and action of insulin on whole-body glucose kinetics in the post-absorptive state and during hyperinsulinaemia were examined in conscious, unrestrained TGR(mRen2)27 rats and age-matched transgene-negative controls. Glucose tolerance and insulin secretion were examined after intravenous administration of 500 mg glucose/kg body weight. Endogenous glucose production and whole-body glucose disposal were estimated using [3-3H]-glucose during euglycaemic-hyperinsulinaemic clamping. Muscle glucose utilization was estimated using 2-deoxy-[1-3H]-glucose. Despite there being higher insulin levels, whole-body glucose turnover was significantly lower in post-absorptive TGR(mRen2)27 rats than it was in transgene-negative controls. This was associated with significant suppression of glucose uptake/phosphorylation by oxidative skeletal muscles. TGR(mRen2)27 rats also exhibited significantly lower blood glucose levels, higher plasma insulin levels and higher rates of disappearance of glucose after intravenous administration of glucose. During hyperinsulinaemia, steady-state glucose infusion rates required to maintain euglycaemia in TGR(mRen2)27 rats were significantly greater, indicating that an increase in whole-body action of insulin had occurred. This was due to significantly greater suppression of endogenous production of glucose: insulin-stimulated glucose disposal rates did not differ significantly between the two groups. The results indicate that TGR(mRen2)27 rats have an enhanced and sensitized insulin-secretory response to glucose, together with a greater than normal hepatic action of insulin. Insulin-mediated glucose disposal was not impaired. The results therefore do not support the hypothesis that hypertension plays a primary role in the development of insulin resistance.Keywords
This publication has 28 references indexed in Scilit:
- Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin???angiotensin-system gene expression and cardiovascular functionsJournal Of Hypertension, 1995
- Differential Gene Expression of Renin and Angiotensinogen in the TGR(mREN-2)27 Transgenic RatHypertension, 1995
- Evidence against a role of insulin in hypertension in spontaneously hypertensive rats. CS-045 does not lower blood pressure despite improvement of insulin resistance.Hypertension, 1994
- Insulin resistance in spontaneously hypertensive rats. Difference in interpretation based on insulin infusion rate or on plasma insulin in glucose clamp studiesDiabetes, 1993
- The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27Endocrinology, 1992
- Effect of insulin on renal sodium handling in hypertensive rats.Hypertension, 1990
- Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 geneNature, 1990
- Abnormalities of carbohydrate metabolism in spontaneously hypertensive ratsJournal of Molecular Medicine, 1988
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987
- Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.Journal of Clinical Investigation, 1985